Stress Trajectories and Anhedonia in Adolescence Research Study
STAARS
2 other identifiers
interventional
192
1 country
1
Brief Summary
This project will examine how multiple biological measures from the brain and the body's stress response system contribute to anhedonia (the loss of pleasure) in adolescence. The goal of this project is to see if it is possible to combine these biological measures to describe different patterns of activity in the brain and body that adolescents may have in response to stress. The main question this study aims to answer is whether different patterns of activity in the brain and body are related to whether adolescents develop anhedonia and how high or low levels of anhedonia are over time. This study will enroll 192 adolescents who are between 13 and 15 years. Adolescents will complete tasks three times: at the beginning of the study, 10 months after that, and then 10 months after that. In total, they will be part of the study for 20 months. At each time, adolescents will complete surveys, provide samples of spit to measure hormones and provide pictures of their brain to measure brain activity, participate in mildly stressful tasks, and complete different activities that measure how they think. The investigators will also ask each adolescent's parent or legal guardian to answer some surveys about themselves and their child.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2025
CompletedFirst Submitted
Initial submission to the registry
June 18, 2025
CompletedFirst Posted
Study publicly available on registry
June 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2030
June 27, 2025
June 1, 2025
4.9 years
June 18, 2025
June 18, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Anhedonia as assessed by the SHAPS
The Snaith-Hamilton Pleasure Scale (SHAPS) is a 14-item measure used to assess anhedonia. Each item has four answer responses: "strongly agree" (1 point), "agree" (2 points), "disagree" (3 points), and "strongly disagree" (4 points). The sum of these responses is taken to find the total score, which ranges from 0-56 with higher scores indicating more overall anhedonia.
Baseline, 10-months, 20-months
Percent signal change during the MIST
During the MIST, research participants complete mental arithmetic with the intermittent reception of neutral and negative evaluative feedback. The percent signal change of the fronto-limbic region of the brain will be analyzed during the MIST task. Higher percent signal change in these regions would indicate higher levels of activation when stressed. Percent signal change ranges between 1% to 5%.
Baseline, 10-Months, 20-Months
Endocrine (cortisol) response during the TSST
The Trier Social Stress Test for Children (TSST-C) -- a social stressor involving story telling in front of two neutral judges, preparation time and a cognitive stressor involving mental arithmetic is used to elicit physiological stress responses. The combination of stressors offers high levels of social-evaluative threat. Cortisol is collected through a saliva sample of passive drool a total of 5 times throughout the visit at 15-minute intervals. The higher the cortisol is found to be, the higher the stress response to the task.
Baseline, 10-Months, 20-Months
Endocrine (cortisol) response during the MIST
During the MIST, research participants complete mental arithmetic with the intermittent reception of neutral and negative evaluative feedback. Cortisol is collected through a saliva sample collected via cotton swab a total of 6 times throughout the visit at 15-minute intervals. The higher the cortisol is found to be, the higher the stress response to the task.
Baseline, 10-Months, 20-Months
Sympathetic and Parasympathetic nervous system ECG activation or heart rate variability (HRV) during a psychosocial stressful task (Trier Social Stress Test - TSST)
The Trier Social Stress Test for Children (TSST-C) -- a social stressor involving story telling in front of two neutral judges, preparation time and a cognitive stressor involving mental arithmetic is used to elicit physiological stress responses. The combination of stressors offers high levels of social-evaluative threat. Throughout the task, heart rate is measured to determine baseline resting state and HRV. HRV is the difference in the milliseconds between each heartbeat. The higher the HRV, the more the nervous system is activated during the task. The level of HRV indicates the participant's nervous system response to stress.
Baseline, 10-Months, 20-Months
Secondary Outcomes (2)
Anhedonia as assessed by the ACIPS
Baseline, 10-months, 20-months
Anhedonia as assessed by the TEPS
Baseline, 10-months, 20-months
Study Arms (1)
Adolescent Teenagers
EXPERIMENTALParticipants aged 13-15 (approximately Tanner pubertal stage 2-4) at study entry.
Interventions
Psychosocial stress procedure consisting of completing sections of mental arithmetic that are 5.5 minutes in length, during which the individual receives neutral and negative evaluative feedback about their performance relative to their peers.
Psychosocial stress procedure in which the individual tells a story for 5 minutes in front of two neutral judges and performs mental arithmetic in front of the judges for 5 minutes.
Eligibility Criteria
You may qualify if:
- Age 13-15 years old at study entry
- Ability to understand and sign an assent form
- Meets study hearing and vision requirements
You may not qualify if:
- Current use of antipsychotic medication
- Current use of medications that would interfere with cardiovascular or endocrine assessments
- Central nervous system disorder or brain injury that could confound brain imaging evaluations
- Presence of a medical condition that would interfere with cardiovascular or endocrine assessments
- Impaired intellectual functioning
- Diagnosed with a neurodevelopmental disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aysenil Belger, PhD
University of North Carolina, Chapel Hill
- PRINCIPAL INVESTIGATOR
Danielle Roubinov, PhD
University of North Carolina, Chapel Hill
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2025
First Posted
June 27, 2025
Study Start
March 12, 2025
Primary Completion (Estimated)
February 1, 2030
Study Completion (Estimated)
February 1, 2030
Last Updated
June 27, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The data will be available to the public after the conclusion of the study and the publication of the manuscripts.
- Access Criteria
- Access to the data is limited to individuals who meet the following data access eligibility criteria as described on the NIMH NDA website: 1. Research Need 2. Electronic Research Administration (eRA) Commons Account 3. Institutional Association 4. Active Federal-Wide Assurance (FWA) 5. NDA Account
In accordance with National Institute of Mental Health (NIMH) policy, all individual-level data will be shared through the NIMH National Data Archive (NDA).